Doximity's (DOCS) Q3 numbers beat estimates; Jefferies 'surprised at weakness' in shares

Go back to Doximity's (DOCS) Q3 numbers beat estimates; Jefferies 'surprised at weakness' in shares

Doximity, Inc. (DOCS) Tops Q3 EPS by 5c, provides guidance

February 8, 2024 4:03 PM EST

Doximity, Inc. (NYSE: DOCS) reported Q3 EPS of $0.29, $0.05 better than the analyst estimate of $0.24. Revenue for the quarter came in at $135.3 million versus the consensus estimate of $127.5 million.

GUIDANCE:

Doximity, Inc. sees Q4 2024 revenue of $115.9-116.9 million, versus the consensus of $118.1... More